Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020

SELL
$106.59 - $164.21 $1.13 Million - $1.74 Million
-10,600 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$113.31 - $150.51 $1.41 Million - $1.87 Million
-12,400 Reduced 53.91%
10,600 $1.21 Million
Q2 2019

Aug 13, 2019

BUY
$115.0 - $141.58 $103,500 - $127,422
900 Added 4.07%
23,000 $3.26 Million
Q1 2019

May 07, 2019

BUY
$98.85 - $134.59 $217,470 - $296,098
2,200 Added 11.06%
22,100 $2.76 Million
Q4 2018

Feb 11, 2019

BUY
$63.81 - $109.82 $1.27 Million - $2.19 Million
19,900 New
19,900 $1.91 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Portfolio

Follow Commonwealth Of Pennsylvania Public School Empls Retrmt Sys and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.